Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Genmab announces positive top-line Phase II results of ofatumumab in multiple sclerosis
Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model.
Genzyme’s Lemtrada Recommended for Reimbursement on NHS by the National Institute for Health and Care Excellence (NICE)
Minocycline inhibits antigen processing for presentation to human T cells: additive inhibition with chloroquine at therapeutic concentrations.
Copolymer-1 promotes neurogenesis and improves functional recovery after acute ischemic stroke in rats.
Genzyme presents second Phase III study of once-daily oral AUBAGIO® (teriflunomide) confirming significant impact on disability
Acorda Therapeutics announces issuance of additional U.S. Patent for AMPYRA® covering a range of dosage strengths
The correlation between symptomatic fatigue to definite measures of gait in people with multiple sclerosis.
Monomethyl fumarate promotes Nrf2-dependent neuroprotection in retinal ischemia-reperfusion.
Gustatory Dysfunction in Multiple Sclerosis
Receptos to deliver scientific presentations about RPC1063 at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
Gene expression studies of a human monocyte cell line identify dissimilarities between differently manufactured glatiramoids.
Cost-effectiveness analysis of interferon beta-1b as treatment for patients with clinically isolated syndrome suggestive of multiple sclerosis in Spain.
Glatiramer acetate treatment negatively regulates type I interferon signaling.
RILUTEK®
Long-term daclizumab therapy in relapsing-remitting multiple sclerosis.
Cladribine impedes in vitro migration of mononuclear cells: a possible implication for treating multiple sclerosis.
The effects of long-term exposure to disease-modifying drugs during pregnancy in multiple sclerosis.
Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder Patients in Turkish Cohort: Demographic, Clinical, and Laboratory Features.
Pattern of demyelination occurring during anti-TNF-α therapy: a French national survey.
Title: Pharmacokinetics and Pharmacodynamics of Peginterferon Beta-1a in Patients with Relapsing-Remitting Multiple Sclerosis in the Randomised ADVANCE Study.
Alemtuzumab improves contrast sensitivity in patients with relapsing-remitting multiple sclerosis.
Rituximab for refractory digital infarcts and ulcers in systemic sclerosis.
Peripheral B cell depletion and central proinflammatory cytokine reduction following repeated intrathecal administration of rituximab in progressive Multiple Sclerosis.
Neuropathology of white matter disease in Leber's hereditary optic neuropathy.

Pages